Home LiteratureArticle Details
PMID: 11165712 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Granulysin expression is a marker for acute rejection and steroid resistance in human renal transplantation.

Human immunology ·Vol. 62 ·No. 1 ·2001-01-00 ·Pages 21-31

Sarwal MM, Jani A, Chang S, Huie P, Wang Z, Salvatierra O, Clayberger C, Sibley R, Krensky AM, Pavlakis M

Abstract

Differentiating etiologies of transplant dysfunction without biopsy and optimizing therapy for acute rejection by predicting steroid resistance will reduce patient morbidity. Granulysin is a cytolytic molecule released by CTL and NK cells and coexpressed with effectors of acute allograft rejection, like perforin and granzymes. Granulysin mRNA and protein expression were studied in peripheral blood lymphocytes (PBL; n = 61 total, n = 10 with intercurrent infections) and biopsy tissue from adult and children renal transplant recipients (n = 97) by competitive quantitative-reverse transcriptase-PCR (QC-RT-PCR) and immunohistochemistry. Differences in cell phenotypes were studied in steroid sensitive and resistant acute rejection biopsies. Granulysin was studied in phytohemagglutinin (PHA) stimulated cell lines (donor PBL and CD45RO(+) T cells) by FACS, Western blotting, and RT-PCR after pretreating with cyclosporine A (CSA), azathioprine, mycophenolic acid, and steroids. Granulysin mRNA was significantly increased in patient PBL and transplant biopsies during acute rejection (p < 0.0001) and infection (p < 0.001). Rejecting biopsies alone (n = 53) had mononuclear cell granulysin staining. Steroid resistant biopsies (n = 25) had denser granulysin staining (>2 cells/high power field) and CD45RO(+) lymphocytes, when compared with steroid sensitive (n = 28) rejecting tissue. Granulysin levels were unchanged after azathioprine and mycophenolic acid treatment, decreased after treating activated PBL with steroids and cyclosporine A (CSA), and paradoxically, increased (p < 0.05) after treating CD45RO(+) CTL with CSA. Elevated PBL granulysin is a peripheral marker for acute rejection and infection and dense granulysin staining a tissue marker for steroid resistance. Memory CTL abound in steroid resistant grafts and may have a markedly different response to CSA immunotherapy, suggesting a possible mechanism for steroid resistance.

MeSH Terms
Acute Disease Adult Antigens, Differentiation, T-Lymphocyte/biosynthesis,blood Biomarkers/blood Blotting, Western Cell Line Child Drug Resistance Flow Cytometry Graft Rejection/blood,diagnosis,drug therapy Humans Immunohistochemistry Kidney/metabolism Kidney Transplantation/immunology Predictive Value of Tests Prednisone/therapeutic use RNA, Messenger/biosynthesis Reverse Transcriptase Polymerase Chain Reaction
Chemicals
Antigens, Differentiation, T-Lymphocyte Biomarkers GNLY protein, human RNA, Messenger Prednisone
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Sarwal M M
Department of Pediatrics, Stanford University, Stanford, CA 94305, USA. msarwal@stanford.edu
Jani A
Chang S
Huie P
Wang Z
Salvatierra O
Clayberger C
Sibley R
Krensky A M
Pavlakis M
Article Info
Journal
Human immunology
Abbr.
Hum Immunol
ISSN
0198-8859
Published
2001-01-00
Pages
21-31
Language
English
Region
United States
NLM ID
8010936
Subset
IM
Grants
NIAID NIH HHS · AI43348-02 · United States
NICHD NIH HHS · HD33698 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com